The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Cancer Cachexia Global Market Report 2024, the cancer cachexia market is expected to show significant growth in the forecast period.

The cancer cachexia market has experienced robust growth in recent years and is expected to continue expanding. This growth is driven by various factors, including an aging population, an increased prevalence of cancer, and advancements in treatment options.

Current Market Size and Growth

• 2023 Market Size: $2.33 billion
• 2024 Market Size: $2.47 billion
• CAGR: 5.9% from 2023 to 2024

This growth is attributed to an improved understanding of cancer biology, a greater focus on patient-centered care, and increased awareness among healthcare providers.

Future Market Projections

• 2028 Market Size: $3.14 billion
• CAGR: 6.2% from 2024 to 2028

Key factors contributing to this growth include rising awareness about cachexia management, expanding geriatric population, adoption of novel therapeutic approaches, increased healthcare expenditure, and supportive government initiatives.

View More On The Cancer Cachexia Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cancer-cachexia-global-market-report

Impact of Cancer Prevalence on the Market

The rising prevalence of cancer significantly impacts the cancer cachexia market:

• Increasing Cancer Cases: Lifestyle changes, environmental factors, and an aging population contribute to the growing number of cancer cases.
• Improved Diagnosis: Enhanced diagnostic methods lead to earlier detection, resulting in a higher number of reported cancer cachexia cases.
• Growing Awareness: More healthcare professionals recognize cachexia symptoms, enabling earlier intervention and treatment.

For instance, in Australia, approximately 1.8% of the population, or 456,200 individuals, had cancer in 2022. Additionally, around 151,000 new cancer diagnoses were made in 2021.

Key Players in the Market

The cancer cachexia market features several major companies actively developing innovative treatments and expanding their offerings:

• Leading Companies: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, and others.
• Focus on Innovation: These companies are investing in research and development to introduce new therapies and improve existing ones, focusing on patient outcomes and quality of life.

Innovative Treatments in the Cancer Cachexia Market

Major companies are developing innovative treatments to manage cancer cachexia:

• Ghrelin Receptor Agonists: Medications like ghrelin receptor agonists activate pathways to regulate body weight, muscle mass, and appetite.
• Example: Helsinn’s Adlumiz (anamorelin), launched in Japan in 2021, is a ghrelin receptor agonist approved to treat cancer cachexia in various cancers, showing effectiveness in increasing body weight and muscle mass.

Strategic Acquisitions to Enhance Cancer Therapies

Acquisitions play a significant role in advancing cancer cachexia treatment options:

• LG Chem’s Acquisition of AVEO Oncology: In January 2023, LG Chem acquired AVEO Oncology to diversify its product portfolio and enhance its capabilities in drug development. This acquisition aims to accelerate innovation in cancer therapies and offer potential treatments for cancer cachexia.

Market Segmentation

The cancer cachexia market is segmented based on therapeutics, mechanisms of action, and distribution channels:

• By Therapeutics: Progestogens, Corticosteroids, Combination Therapies, Other Therapeutics
• By Mechanism of Action: Appetite Stimulators, Weight Loss Stabilizers, Other Mechanisms of Actions
• By Distribution Channel: Hospital Stores, Retail Pharmacy Stores, Online Pharmacies

Regional Insights

• Largest Region (2023): North America
• Fastest-Growing Region: Asia-Pacific

The cancer cachexia market is poised for significant growth in the coming years, driven by increasing cancer prevalence, innovative treatments, and strategic acquisitions. With advancements in diagnosis and supportive care, the market will likely continue expanding, offering improved options for managing cancer cachexia.

Request A Sample Of The Global Cancer Cachexia Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15527&type=smp